Safety and Efficacy of PD‐1/PD‐L1 inhibitors combined with radiotherapy in patients with non‐small‐cell lung cancer: a systematic review and meta‐analysis

BACKGROUND: A combination of programmed cell death protein‐1 (PD‐1)/programmed cell death ligand‐1 (PD‐L1) inhibitors and radiotherapy (RT) is increasingly being used to treat non‐small‐cell lung cancer (NSCLC). However, the safety and efficacy of this approach remains controversial. We performed a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Geng, Yichao, Zhang, Qiuning, Feng, Shuangwu, Li, Chengcheng, Wang, Lina, Zhao, Xueshan, Yang, Zhen, Li, Zheng, Luo, Hongtao, Liu, Ruifeng, Lu, Bing, Wang, Xiaohu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7926021/
https://ncbi.nlm.nih.gov/pubmed/33465302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3718
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados